3Jabs WJ, Logering BA, Gerke P, et al. Kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol, 2003, 33:152 - 161.
4Shrive AK, Gheetham GM, Holden D, et al. Three dimensional structure of h uman C-reactive protein. Nature Struc Biol, 1996, 3:346 -354.
5Angrawal A, Lee S, Carson M, et al. Site-directed mutagenesis of the phosphocholine-binding site of human C-reactive protein: role of Thr76 and Trp67. J Immunol, 1997, 158:345 -350.
6Pasceri Ⅴ, Willerson JT, Yeh ET. Direct proinflammatory effect of Creactive protein on human endothelial cells. Circulation, 2000, 102:2165 -2168.
7Pasceri Ⅴ, Cheng JS, Willerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation, 2001,103:2531 -2534.
8Torzewki J, Torzewski M, Bower DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol, 1998, 18:1386 - 1392.
9Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood, 1993,82:513 -520.
10Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997: 336:973 -979.
6Oh SH,Lee JG,Na SJ,et al.Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level[J].Arch Neurol,2003,60(1):37-41.
7Raza AJ, Movahed A. Current concepts of cardiovascular diseases in diabetes mellitus[J]. Int J Cardiol, 2003,89 (2/ 3):123-134.
